HER2-positive early breast cancer

Roche seeks FDA approval for Kadcyla in HER2-positive early breast cancer
Pharmaceutical Business Review
Tue, 02/5/19 - 10:18 am
Roche
FDA
Kadcyla
HER2-positive early breast cancer